ConductScience.org, home

Paper39499641

VEGF inhibition increases expression of HIF-regulated angiogenic genes by the RPE limiting the response of wet AMD eyes to aflibercept.

Sharma D and 13 others. Proc Natl Acad Sci U S A, 2024. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. VEGF inhibition increases expression of HIF-regulated angiogenic genes by the RPE limiting the response of wet AMD eyes to aflibercept. Papers, record 39499641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39499641

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
VEGF inhibition increases expression of HIF-regulated angiogenic genes by the RPE limiting the response of wet AMD eyes to aflibercept.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, N.I.H., Intramural
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
2.56, provisional
iCite
Revised in PubMed
2026-08-04
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sharma DDeeptihttps://orcid.org/0000-0002-1824-6995
2Lau EEvan
3Qin YYuhttps://orcid.org/0000-0001-9154-1432
4Jee KKathleen
5Rodrigues MMurilo
6Guo CChuanyu
7Dinabandhu AAumreetamhttps://orcid.org/0000-0002-2879-5031
8McIntyre EEmma
9Salman SShaimahttps://orcid.org/0000-0002-2002-3117
10Hwang YYousang
11Moshiri AAla
12Semenza GLGregg Lhttps://orcid.org/0000-0002-0913-211X
13Montaner SSilvia
14Sodhi AAkrit

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Receptors, Vascular Endothelial Growth FactorMajor topic
Angiopoietin-Like Protein 4Major topic
Retinal Pigment EpitheliumMajor topic
Vascular Endothelial Growth Factor AMajor topic
Hypoxia-Inducible Factor 1, alpha SubunitMajor topic
Recombinant Fusion ProteinsMajor topic
Choroidal NeovascularizationMajor topic
Animals
Humans
Mice
Wet Macular Degeneration
Angiogenesis Inhibitors
Gene Expression Regulation
Male
Female

Source PubMed

Download CSV of topics

Grants10

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
Sybil B. Harrington Stein Innovation AwardResearch to Prevent Blindness (RPB)PubMedPubMed
P30 EY001765NEI NIH HHSUnited StatesP30EY001765PubMed and NIHNIH RePORTER
TEDCO Maryland Innovation InitiativeState of Maryland (The State of Maryland)PubMedPubMed
unrestricted grantResearch to Prevent Blindness (RPB)PubMedPubMed
R01 EY032104NEI NIH HHSUnited StatesR01EY032104PubMed and NIHNIH RePORTER
Branna and Irving Sisenwein ProfessorshipBranna and Irving Sisenwein ProfessorshipPubMedPubMed
R01 EY029750NEI NIH HHSUnited StatesR01EY029750PubMed and NIHNIH RePORTER
Special Scholar AwardResearch to Prevent Blindness (RPB)PubMedPubMed
EY001765HHS | NIH | National Eye Institute (NEI)P30EY001765PubMed and NIHNIH RePORTER
C. Michael Armstrong ProfessorshipArmstrong Family FoundationPubMedPubMed

Download CSV of grants

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12587050Atrophic macular degeneration. Rate of spread of geographic atrophy and visual loss.Ophthalmology1989https://conductscience.org/library/papers/2587050PubMed
29486038Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes.Br J Ophthalmol1997https://conductscience.org/library/papers/9486038PubMed
39204896Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.Science1997https://conductscience.org/library/papers/9204896PubMed
427156698Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials.Ophthalmology2016https://conductscience.org/library/papers/27156698PubMed
522523653Anti-VEGF Treatment Strategies for Wet AMD.J Ophthalmol2012https://conductscience.org/library/papers/22523653PubMed
619834034Vascular endothelial growth factor as an autocrine survival factor for retinal pigment epithelial cells under oxidative stress via the VEGF-R2/PI3K/Akt.Invest Ophthalmol Vis Sci2010https://conductscience.org/library/papers/19834034PubMed
724727261Sporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).Am J Ophthalmol2014https://conductscience.org/library/papers/24727261PubMed
831545295Angiopoietin-like 4 binds neuropilins and cooperates with VEGF to induce diabetic macular edema.J Clin Invest2019https://conductscience.org/library/papers/31545295PubMed
926477842Ranibizumab or Bevacizumab for Neovascular Age-Related Macular Degeneration According to the Lucentis Compared to Avastin Study Treat-and-Extend Protocol: Two-Year Results.Ophthalmology2016https://conductscience.org/library/papers/26477842PubMed
1026469243Angiopoietin-like 4 as an Emerging Therapeutic Target for Diabetic Eye Disease.JAMA Ophthalmol2015https://conductscience.org/library/papers/26469243PubMed
1120065104Digoxin inhibits retinal ischemia-induced HIF-1alpha expression and ocular neovascularization.FASEB J2010https://conductscience.org/library/papers/20065104PubMed
1237227777Targeting hypoxia-inducible factors with 32-134D safely and effectively treats diabetic eye disease in mice.J Clin Invest2023https://conductscience.org/library/papers/37227777PubMed
1323701276Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases.Curr Drug Targets2013https://conductscience.org/library/papers/23701276PubMed
1432045141Aflibercept and Ranibizumab Modulate Retinal Pigment Epithelial Cells Function by Acting on Their Cross Talk with Vascular Endothelial Cells.Cell Physiol Biochem2020https://conductscience.org/library/papers/32045141PubMed
1530834517Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.Cochrane Database Syst Rev2019https://conductscience.org/library/papers/30834517PubMed
1626039997Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy.Proc Natl Acad Sci U S A2015https://conductscience.org/library/papers/26039997PubMed
1719805192Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization.Proc Natl Acad Sci U S A2009https://conductscience.org/library/papers/19805192PubMed
1824875610Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trials.JAMA Ophthalmol2014https://conductscience.org/library/papers/24875610PubMed
1934874918Aqueous proteins help predict the response of patients with neovascular age-related macular degeneration to anti-VEGF therapy.J Clin Invest2022https://conductscience.org/library/papers/34874918PubMed
20613523Senile macular degeneration: a histopathologic study.Trans Am Ophthalmol Soc1977https://conductscience.org/library/papers/613523PubMed

See all 50 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
42752553Angiopoietin-Like 4 Induces Upregulation of VEGF and sVCAM1 Through JNK/c-Jun and JAK2/STAT5 Signaling Pathways.Invest Ophthalmol Vis Sci2026https://conductscience.org/library/papers/42752553PubMed
42326539An intraocular oxygenated emulsion suppresses retinal fibrosis by inhibiting hypoxia-driven bioenergetic shifts and mesenchymal transformation.Res Sq2026https://conductscience.org/library/papers/42326539PubMed
41978200Cocoa Powder Modulates HIF-1α Stability and Inhibits Ocular Angiogenic and Degenerative Pathology.Nutrients2026https://conductscience.org/library/papers/41978200PubMed
41898816Precision Is Not Enough: When Tools Outpace Translation in Ocular Gene Therapy.Genes (Basel)2026https://conductscience.org/library/papers/41898816PubMed
41805097Silencing of lncRNA HOTAIR Using Eyedrops as a Potential Treatment for Diabetes-Associated Retinal Dysregulation and Dysfunction.Invest Ophthalmol Vis Sci2026https://conductscience.org/library/papers/41805097PubMed
41766669Molecular stress and neurovascular injury in the diabetic retina.J Clin Invest2026https://conductscience.org/library/papers/41766669PubMed
41575610Enhancing the efficacy of VEGF inhibitors by co-inhibition of HIF in the treatment of glioblastoma.Apoptosis2026https://conductscience.org/library/papers/41575610PubMed
41082699Hesperidin and Hesperetin from Orange Peel Water Extract Protect against NaIO3-Induced Oxidative Damage in Retinal Pigment Epithelial Cells by Modulating PI3K/Akt/HIF-1α/BNIP3 Signaling.J Agric Food Chem2025https://conductscience.org/library/papers/41082699PubMed
40937643PM2.5 exposure induces transcriptomic changes in ARPE-19 cells with activation of TGFβ-mediated signaling pathways: A next-generation sequencing approach.J Chin Med Assoc2025https://conductscience.org/library/papers/40937643PubMed
40668060Inhibition of Endothelial HIF-1α by IDF-11774 Attenuates Retinal Neovascularization and Vascular Leakage.Invest Ophthalmol Vis Sci2025https://conductscience.org/library/papers/40668060PubMed
40493193Feedback regulation between histone lactylation and ALKBH3-mediated glycolysis regulates age-related macular degeneration pathology.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40493193PubMed
40448612SUMOylation is a Translatable Target in Hypoxic MNPs Regulating Retinal Vasculopathy.Adv Sci (Weinh)2025https://conductscience.org/library/papers/40448612PubMed
40265403Novel Therapeutic Approaches for Treatment of Diabetic Retinopathy and Age-Related Macular Degeneration.Vision (Basel)2025https://conductscience.org/library/papers/40265403PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ANGPTL451129PubTator's text mininghttps://conductscience.org/library/genes/51129NCBI Gene
HIF1A3091PubTator's text mininghttps://conductscience.org/library/genes/3091NCBI Gene
KDR3791PubTator's text mininghttps://conductscience.org/library/genes/3791NCBI Gene
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39499641

GET https://conductscience.org/api/papers/v1/39499641/references?page=2